Published by Global Banking and Finance Review
Posted on January 12, 2026

Published by Global Banking and Finance Review
Posted on January 12, 2026

Jan 12 (Reuters) - British medical products maker Smith & Nephew will buy U.S.-based Integrity Orthopaedics in a deal that could be valued at up to $450 million, the company said on Monday.
The deal comes a month after Smith & Nephew said it will simplify its portfolio after restructuring the orthopedic division, its largest, as part of its successful three-year turnaround plan.
Smith & Nephew will make an initial cash payment of $225 million to Integrity and additional performance-based payments worth up to $225 million over the next five years.
The company said it will finance the deal from its existing cash facilities.
The group, which manufactures in the UK, Switzerland, Costa Rica, Malaysia and China, has been adjusting its production volumes and raw material flows to mitigate tariff costs.
The deal is expected to be accretive to the company's trading profit margin by 2028, it said.
Integrity Orthopaedics is an early‑stage commercial developer of rotator cuff repair systems designed to reduce re‑tear rates.
(Reporting by Sri Hari N S in Bengaluru; Editing by Sahal Muhammed)
An acquisition is a corporate action in which one company purchases most or all of another company's shares to gain control of that company.
Financial services refer to the economic services provided by the finance industry, which encompasses a broad range of businesses that manage money, including banks, investment funds, and insurance companies.
Profit margin is a financial metric that indicates the percentage of revenue that exceeds the costs of goods sold (COGS). It is a measure of a company's profitability.
A performance-based payment is a type of compensation that is contingent upon achieving specific performance targets or outcomes.
Explore more articles in the Finance category

